These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 26991320)

  • 1. Synthesis of (3) H, (2) H4 and (14) C-SCH 417690 (Vicriviroc).
    Hesk D; Borges S; Hendershot S; Koharski D; McNamara P; Ren S; Saluja S; Truong V; Voronin K
    J Labelled Comp Radiopharm; 2016 May; 59(5):190-6. PubMed ID: 26991320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis of
    Hesk D; Borges S; Dumpit R; Hendershot S; Koharski D; McNamara P; Ren S; Saluja S; Truong V; Voronin K
    J Labelled Comp Radiopharm; 2017 Apr; 60(4):194-199. PubMed ID: 28129428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis of
    Hesk D; Koharski D; McNamara P; Royster P; Saluja S; Truong V; Voronin K
    J Labelled Comp Radiopharm; 2018 Jun; 61(7):533-539. PubMed ID: 29493011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Syntheses of (3) H-labeled, (14) C-labeled, and (2) H4 -labeled SCH 444877, phosphodiesterase type 5 inhibitors.
    Ren S; Hesk D; McNamara P; Koharski D; Hendershot S
    J Labelled Comp Radiopharm; 2013; 56(9-10):480-4. PubMed ID: 24285525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Syntheses of a radiolabelled CXCR2 antagonist AZD5069 and its major human metabolite.
    Hickey MJ; Allen PH; Caffrey M; Hansen P; Kingston LP; Wilkinson DJ
    J Labelled Comp Radiopharm; 2016 Sep; 59(11):432-8. PubMed ID: 27461061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery and characterization of vicriviroc (SCH 417690), a CCR5 antagonist with potent activity against human immunodeficiency virus type 1.
    Strizki JM; Tremblay C; Xu S; Wojcik L; Wagner N; Gonsiorek W; Hipkin RW; Chou CC; Pugliese-Sivo C; Xiao Y; Tagat JR; Cox K; Priestley T; Sorota S; Huang W; Hirsch M; Reyes GR; Baroudy BM
    Antimicrob Agents Chemother; 2005 Dec; 49(12):4911-9. PubMed ID: 16304152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of 3H, 13C,2H3,15N and 14C-labelled SCH 466036, a histamine 3 receptor antagonist.
    Hesk D; Borges S; Dumpit R; Hendershot S; Koharski D; Lavey C; McNamara P; Voronin K
    J Labelled Comp Radiopharm; 2015 Feb; 58(2):36-41. PubMed ID: 25689968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The synthesis of tritium, carbon-14 and stable isotope labelled selective estrogen receptor degraders.
    Bragg RA; Bushby N; Ericsson C; Kingston LP; Ji H; Elmore CS
    J Labelled Comp Radiopharm; 2016 Sep; 59(11):454-61. PubMed ID: 27558079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis of [(3) H], [(13) C3 , (15) N], and [(14) C]SCH 900567: an inhibitor of TNF-α (tumor necrosis factor alpha) converting enzyme (TACE).
    Ren S; Hesk D; McNamara P; Koharski D; Borges S
    J Labelled Comp Radiopharm; 2014 Sep; 57(11):632-6. PubMed ID: 25251383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Piperazine-based CCR5 antagonists as HIV-1 inhibitors. IV. Discovery of 1-[(4,6-dimethyl-5-pyrimidinyl)carbonyl]- 4-[4-[2-methoxy-1(R)-4-(trifluoromethyl)phenyl]ethyl-3(S)-methyl-1-piperazinyl]- 4-methylpiperidine (Sch-417690/Sch-D), a potent, highly selective, and orally bioavailable CCR5 antagonist.
    Tagat JR; McCombie SW; Nazareno D; Labroli MA; Xiao Y; Steensma RW; Strizki JM; Baroudy BM; Cox K; Lachowicz J; Varty G; Watkins R
    J Med Chem; 2004 May; 47(10):2405-8. PubMed ID: 15115380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiosynthesis of
    Vaidyanathan S; Reed A; Du J
    J Labelled Comp Radiopharm; 2021 Jul; 64(9):356-362. PubMed ID: 34050966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of [H-3]- and [C-14]-labeled elagolix.
    Soli ED; Surber BW; Reed AD
    J Labelled Comp Radiopharm; 2021 Jun; 64(7):254-261. PubMed ID: 33675109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of selectively labeled histidine and its methylderivatives with deuterium, tritium, and carbon-14.
    Šamonina-Kosicka J; Kańska M
    J Labelled Comp Radiopharm; 2013 May; 56(6):317-20. PubMed ID: 24285411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and characterization of INCB9471, an allosteric noncompetitive small-molecule antagonist of C-C chemokine receptor 5 with potent inhibitory activity against monocyte migration and HIV-1 infection.
    Shin N; Solomon K; Zhou N; Wang KH; Garlapati V; Thomas B; Li Y; Covington M; Baribaud F; Erickson-Viitanen S; Czerniak P; Contel N; Liu P; Burn T; Hollis G; Yeleswaram S; Vaddi K; Xue CB; Metcalf B; Friedman S; Scherle P; Newton R
    J Pharmacol Exp Ther; 2011 Jul; 338(1):228-39. PubMed ID: 21459966
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis of [
    Queen AE; Hesk D; Lindsay DM; Kerr WJ; Rehder K; Fennell T; Mascarella W; Zhong D; Runyon S
    J Labelled Comp Radiopharm; 2020 Apr; 63(4):196-202. PubMed ID: 32017204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The syntheses of isotopically labelled CB-1 antagonists for the treatment of obesity.
    Tran SB; Maxwell BD; Burrell R; Bonacorsi SJ
    J Labelled Comp Radiopharm; 2016 Dec; 59(14):665-672. PubMed ID: 27624665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The synthesis of a tritium, carbon-14, and stable isotope-labeled cathepsin C inhibitors.
    Allen P; Bragg RA; Caffrey M; Ericsson C; Hickey MJ; Kingston LP; Elmore CS
    J Labelled Comp Radiopharm; 2017 Feb; 60(2):124-129. PubMed ID: 27868229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Forward- and reverse-synthesis of piperazinopiperidine amide analogs: a general access to structurally diverse 4-piperazinopiperidine-based CCR5 antagonists.
    Feng DZ; Song YL; Jiang XH; Chen L; Long YQ
    Org Biomol Chem; 2007 Aug; 5(16):2690-7. PubMed ID: 18019544
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation of tritium-labeled PF-622, a novel fatty acid amide hydrolase inhibitor.
    Zhang Y
    J Labelled Comp Radiopharm; 2017 Nov; 60(13):608-615. PubMed ID: 28869999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the efficiency of Pd/H2 -catalyzed benzylic H/D exchange of dehydroabietinal with D(2) O and synthesis of a tritium-labeled analogue.
    Petros RA; Shah J
    J Labelled Comp Radiopharm; 2014 Jan; 57(1):53-6. PubMed ID: 24448746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.